Role of the angiotensin II type-2 receptor in radiation nephropathy (Q36082536)

12 August 2017

Role of the angiotensin II type-2 receptor in radiation nephropathy (English)

1 reference

12 August 2017

Eric P Cohen

1

1 reference

12 August 2017

Brian L Fish

2

1 reference

12 August 2017

Mukut Sharma

3

1 reference

12 August 2017

X Allen Li

4

1 reference

12 August 2017

John E Moulder

5

1 reference

12 August 2017

25 May 2007

1 reference

12 August 2017

Translational Research

1 reference

12 August 2017

150

1 reference

12 August 2017

2

1 reference

12 August 2017

106-115

1 reference

Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Renal dysfunction after total body irradiation: dose-effect relationship

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

AT(2) receptors mediate tonic renal medullary vasoconstriction in renovascular hypertension.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Renal toxicity after radionuclide therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

AT1 and AT2 receptor in the kidney: role in health and disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

2 October 2017

Radiation nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

A computer program for comparing K samples with right-censored data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Distribution of angiotensin II receptor subtypes in rat and human kidney

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

An extremely high dose of losartan affords superior renoprotection in the remnant model

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Impact of angiotensin II type 2 receptor blockade on experimental radiation nephropathy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Successful treatment of radiation nephropathy with angiotensin II blockade.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2034340

Long-term enalapril and hydrochlorothiazide in radiation nephritis

23 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Angiotensin II infusion exacerbates radiation nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Late toxicity of total body irradiation with bone marrow transplantation in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

The renin-angiotensin system in experimental radiation nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Successful brief captopril treatment in experimental radiation nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Brief pharmacological intervention in experimental radiation nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

"The road not taken": role of angiotensin II type 2 receptor in pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.03.004

Angiotensin IV AT4-receptor system in the rat kidney

7 January 2021

1 reference

12 December 2020

Angiotensin II receptor subtypes in cultured rat renal mesangial cells

1 reference

12 December 2020

In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist

1 reference

12 December 2020

Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats

1 reference

12 December 2020

10.1016/J.TRSL.2007.03.004

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

17656330

1 reference